首页> 美国卫生研究院文献>Journal of Physical Therapy Science >Efficacy of subcutaneous lidocaine injection in venous insufficiency: aprospective randomized controlled study and new treatment protocol
【2h】

Efficacy of subcutaneous lidocaine injection in venous insufficiency: aprospective randomized controlled study and new treatment protocol

机译:皮下注射利多卡因治疗静脉功能不全的疗效:前瞻性随机对照研究和新治疗方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

[Purpose] The purpose of this study was to evaluate the efficacy of subcutaneous injection with lidocaine in patients with chronic venous insufficiency in the early stage. [Subjects and Methods] Patients (n=50) randomized to the treatment group received subcutaneous injections from a mixture of physiological saline sterile solution and lidocaine once a week to both legs below the knee for 5 sessions. Patients in the treatment group were also given ankle pumping exercises and compression stockings throughout the treatment. Patients randomized to the control group (n=50) received only ankle pumping exercises and compression stockings. Patients were evaluated using the visual analog scale (VAS) for pain and Chronic Venous Disease Quality of life Questionnaire (CIVIQ-20) for quality-of-life at months 1, 3, 6, at the end of month 12, and at the end of the injection treatment for 5 sessions. [Results] CIVIQ-20 and VAS results were significantly lower in the treatment group, than in the control group at months 1, 3 and 6. However, CIVIQ-20 and VAS results were not significantly different, compared with the pre-operative period at month 12. [Conclusion] We observed that 5-week subcutaneous lidocaine injection treatment was effective in patients who do not respond to oral medical treatment or in whom surgery is not considered.
机译:[目的]本研究的目的是评估皮下注射利多卡因对早期慢性静脉功能不全患者的疗效。 [受试者和方法]随机分为治疗组的患者(n = 50)每周一次从生理盐水无菌溶液和利多卡因的混合物中皮下注射至膝盖以下的双腿,共5次。在整个治疗过程中,治疗组的患者还接受了踝关节抽脂运动和压力袜。随机分为对照组(n = 50)的患者仅接受踝关节抽脂运动和加压袜。使用视觉模拟量表(VAS)对患者进行疼痛评估,并对慢性静脉疾病生活质量问卷(CIVIQ-20)在第1、3、6个月,第12个月末和第12个月末进行生活质量评估。注射治疗结束5个疗程。 [结果]在治疗第1、3和6个月,治疗组的CIVIQ-20和VAS结果显着低于对照组。但是,与术前相比,CIVIQ-20和VAS的结果无明显差异。在第12个月时。[结论]我们观察到,对口服药物治疗无反应或不考虑手术的患者,皮下注射利多卡因5周治疗有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号